EXT1

Chr 8ADSomatic

exostosin glycosyltransferase 1

Also known as: EXT, LGCR, LGS, TRPS2, TTV

This gene encodes an endoplasmic reticulum-resident type II transmembrane glycosyltransferase involved in the chain elongation step of heparan sulfate biosynthesis. Mutations in this gene cause the type I form of multiple exostoses. [provided by RefSeq, Jul 2008]

GeneReviewsOMIMResearchGenerating clinical summary…
LOFmechanismAD/SomaticLOEUF 0.263 OMIM phenotypes
Clinical SummaryEXT1
🧬
Gene-Disease Validity (ClinGen)
exostoses, multiple, type 1 · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
552 unique Pathogenic / Likely Pathogenic· 394 VUS of 1269 total submissions
💊
Clinical Trials
2 active or recruiting trials — potential therapeutic options may be available
📖
GeneReview available — EXT1
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint?
0.26LOEUF
pLI 0.997
Z-score 4.86
OE 0.11 (0.060.26)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
1.67Z-score
OE missense 0.77 (0.700.84)
317 obs / 412.2 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.11 (0.060.26)
00.351.4
Missense OE?0.77 (0.700.84)
00.61.4
Synonymous OE?1.07
01.21.6
LoF obs/exp: 4 / 35.0Missense obs/exp: 317 / 412.2Syn Z: -0.73
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveEXT1-related multiple exostosesLOFAD
definitiveEXT1-related trichorhinopharangeal syndrome (Langer-Giedon)LOFAD

This gene — mechanism propensity

DN
0.3793th %ile
GOF
0.3292th %ile
LOF
0.67top 25%

The highest-scoring mechanism for this gene is loss-of-function (haploinsufficiency).

LOFprediction above median · 1 literature citation · 85% of P/LP variants are LoF · LOEUF 0.26 · ClinGen HI: Sufficient evidence for dosage pathogenicity

Literature Evidence

LOFLanger-Giedion's syndrome (LGS) or trichorhinophalangeal syndrome type II (TRPS II; MIM:150230) is a contiguous gene deletion syndrome caused by the haploinsufficiency of the TRPS1 and EXT1 genes.1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

References

  1. 1.PMID 31976145

ClinVar Variant Classifications

1269 submitted variants in ClinVar

Classification Summary

Pathogenic476
Likely Pathogenic76
VUS394
Likely Benign223
Benign46
Conflicting38
476
Pathogenic
76
Likely Pathogenic
394
VUS
223
Likely Benign
46
Benign
38
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
423
27
26
0
476
Likely Pathogenic
44
28
4
0
76
VUS
9
347
35
3
394
Likely Benign
0
9
73
141
223
Benign
0
5
29
12
46
Conflicting
38
Total4764161671561,253

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

65 pathogenic / likely-pathogenic (of 73) ClinVar copy-number / structural variants overlap EXT1 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

EXT1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.